Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Aug 28;48(8):1113-1127. doi: 10.11817/j.issn.1672-7347.2023.230128.
Being the leading cause of death among both urban and rural residents in Hunan Province, China, cardiovascular and cerebrovascular diseases hold a significant position in the region's public health landscape. Their prevalence and impact not only underscore the urgency of effective disease prevention and control but also provide crucial guidance for future initiatives. Consequently, the (2020) hereinafter referred to as the "Annual Report", serves as an extensive and informative document. It meticulously examines the current status of these diseases, highlighting both the existing challenges and opportunities for prevention and control efforts in Hunan Province. The primary objective of this report is to furnish valuable insights and evidence that will empower and enrich future endeavors aimed at combatting cardiovascular and cerebrovascular diseases within the region. In 2017, the year of life expectancy lost due to cardiovascular and cerebrovascular diseases in Hunan Province remained higher than the national average. Additionally, the per capita life expectancy in 2019 (77.1 years) was slightly lower by 0.2 years compared with the national average (77.3 years). Alarmingly, the mortality rates associated with cardiovascular and cerebrovascular diseases were consistently ranking highest, indicating an upward trajectory. Moreover, the prevalence and mortality rates of conditions such as hypertension, coronary heart disease, and stroke, all encompassed within the domain of cardiovascular and cerebrovascular diseases, surpassed the national averages. Consequently, the economic burden attributable to cardiovascular and cerebrovascular diseases is on the rise. And under vertical comparison, in 2019, the life expectancy per capita in Hunan Province increased by 1.26 years compared with 2015. The incidence rate of cardiovascular and cerebrovascular events decreased by 8.34% compared with 2017. A new model of hypertension medical and preventive integration has been established with the efforts of many experts in Hunan Province, and full coverage of standardised outpatient clinics for hypertension at the grassroots level has been realised. The rate of standardised management of patients with hypertension under management in Changsha County, a demonstration area, rose to 65.27%, and the incidence rate of cardiovascular and cerebrovascular events, the incidence rate of stroke, and the mortality rate due to cardiovascular and cerebrovascular events were reduced by 28.08%, 28.62%, and 25.00%, respectively. Hunan Province has made significant strides in the prevention and control of cardiovascular and cerebrovascular diseases in recent years.
在中国湖南省,心血管疾病和脑血管疾病是城乡居民的主要死亡原因,在该地区的公共卫生领域占有重要地位。这些疾病的流行程度和影响不仅突出了有效疾病预防和控制的紧迫性,而且为未来的举措提供了重要的指导。因此,(2020 年)以下简称“年度报告”,是一份广泛而详实的文件。它仔细研究了这些疾病的现状,强调了湖南省在预防和控制这些疾病方面存在的挑战和机遇。本报告的主要目的是提供有价值的见解和证据,为该地区未来打击心血管疾病和脑血管疾病的努力提供支持和丰富。2017 年,湖南省因心血管疾病和脑血管疾病而损失的预期寿命仍高于全国平均水平。此外,2019 年人均预期寿命(77.1 岁)比全国平均水平(77.3 岁)低 0.2 岁。令人震惊的是,心血管疾病和脑血管疾病的死亡率一直居高不下,呈上升趋势。此外,高血压、冠心病和中风等心血管疾病和脑血管疾病涵盖的疾病的患病率和死亡率均高于全国平均水平。因此,心血管疾病和脑血管疾病造成的经济负担正在上升。而且,与纵向比较相比,2019 年湖南省人均预期寿命比 2015 年增加了 1.26 年。与 2017 年相比,心血管和脑血管事件的发病率下降了 8.34%。湖南省众多专家共同建立了高血压医疗与预防相结合的新模式,实现了基层高血压标准化门诊全覆盖。高血压管理患者的标准化管理率在长沙市示范区上升到 65.27%,心血管和脑血管事件发生率、中风发生率和心血管和脑血管事件死亡率分别降低了 28.08%、28.62%和 25.00%。近年来,湖南省在心血管疾病和脑血管疾病的预防和控制方面取得了重大进展。